58 related articles for article (PubMed ID: 17167759)
1. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
[TBL] [Abstract][Full Text] [Related]
2. Lymphopenia associated with survivin and its downstream pathway in COVID-19 serving as a potential route in COVID-19 pathogenesis.
Kahrizi MS; Nasiri K; Ebrahimzadeh F; Yaseri AF; Ghodratizadeh S; Gholamrezaei M; Rahat Dahmardeh A; Adili A; Amjidifar R; Hemmatzadeh M; Arabi M; Maghsoudi MR; Mohammadi H
Adv Med Sci; 2024 Mar; 69(1):190-197. PubMed ID: 38521459
[TBL] [Abstract][Full Text] [Related]
3. Survivin, β-catenin, and ki-67 immunohistochemical expression in canine perivascular wall tumors: Preliminary assessment of prognostic significance.
Godizzi F; Armando F; Boracchi P; Avallone G; Stefanello D; Ferrari R; Chiti LE; Cappelleri A; Zamboni C; Dell'Aere S; Corradi A; Roccabianca P
Vet Pathol; 2024 May; ():3009858241246981. PubMed ID: 38727195
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis identifies BIRC5 as a prognostic biomarker.
Fäldt Beding A; Larsson P; Helou K; Einbeigi Z; Parris TZ
BMC Cancer; 2022 Mar; 22(1):322. PubMed ID: 35331169
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis.
Gąsowska-Bajger B; Gąsowska-Bodnar A; Knapp P; Bodnar L
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33669912
[TBL] [Abstract][Full Text] [Related]
6. DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death.
Thibault B; Genre L; Le Naour A; Broca C; Mery E; Vuagniaux G; Delord JP; Wiedemann N; Couderc B
Sci Rep; 2018 Dec; 8(1):17862. PubMed ID: 30552344
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.
Li S; Wang L; Meng Y; Chang Y; Xu J; Zhang Q
Oncotarget; 2017 Jun; 8(25):41282-41293. PubMed ID: 28476037
[TBL] [Abstract][Full Text] [Related]
8. microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
Li X; Chen W; Zeng W; Wan C; Duan S; Jiang S
Br J Cancer; 2017 Jan; 116(1):66-76. PubMed ID: 27875524
[TBL] [Abstract][Full Text] [Related]
9. XIAP RING domain mediates miR-4295 expression and subsequently inhibiting p63α protein translation and promoting transformation of bladder epithelial cells.
Jin H; Xu J; Guo X; Huang H; Li J; Peng M; Zhu J; Tian Z; Wu XR; Tang MS; Huang C
Oncotarget; 2016 Aug; 7(35):56540-56557. PubMed ID: 27447744
[TBL] [Abstract][Full Text] [Related]
10. Survivin and cycline D1 expressions are associated with malignant potential in mucinous ovarian neoplasms.
Kanter M; Turan G; Usta C; Usta A; Esen HH; Tavlı L; Celik C; Demirkol Y; Kanter B
J Mol Histol; 2016 Apr; 47(2):145-52. PubMed ID: 26815661
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer.
Du J; Li B; Fang Y; Liu Y; Wang Y; Li J; Zhou W; Wang X
BMC Cancer; 2015 Jul; 15():536. PubMed ID: 26198101
[TBL] [Abstract][Full Text] [Related]
12. BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma.
Davidson B; Nymoen DA; Elgaaen BV; Staff AC; Tropé CG; Kærn J; Reich R; Falkenthal TE
Virchows Arch; 2014 Jun; 464(6):701-7. PubMed ID: 24756216
[TBL] [Abstract][Full Text] [Related]
13. Txr1: an important factor in oxaliplatin resistance in gastric cancer.
Bi J; Bai Z; Ma X; Song J; Guo Y; Zhao J; Yi X; Han S; Zhang Z
Med Oncol; 2014 Feb; 31(2):807. PubMed ID: 24362794
[TBL] [Abstract][Full Text] [Related]
14. Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.
Le Page C; Huntsman DG; Provencher DM; Mes-Masson AM
Cancers (Basel); 2010 May; 2(2):913-54. PubMed ID: 24281100
[TBL] [Abstract][Full Text] [Related]
15. Sandwich ELISA for detecting urinary Survivin in bladder cancer.
Li X; Wang Y; Xu J; Zhang Q
Chin J Cancer Res; 2013 Aug; 25(4):375-81. PubMed ID: 23997523
[TBL] [Abstract][Full Text] [Related]
16. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
[TBL] [Abstract][Full Text] [Related]
17. Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases.
Davidson B; Holth A; Nguyen MT; Tropé CG; Wu C
Gynecol Oncol; 2013 Feb; 128(2):364-70. PubMed ID: 23099104
[TBL] [Abstract][Full Text] [Related]
18. ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival.
Elgaaen BV; Olstad OK; Sandvik L; Odegaard E; Sauer T; Staff AC; Gautvik KM
PLoS One; 2012; 7(9):e46317. PubMed ID: 23029477
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion.
Li J; Li ZN; Bao QL; Ge LP; Li XQ; Chen P
Tumour Biol; 2012 Oct; 33(5):1803-10. PubMed ID: 22696161
[TBL] [Abstract][Full Text] [Related]
20. E3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activity.
Liu J; Zhang D; Luo W; Yu J; Li J; Yu Y; Zhang X; Chen J; Wu XR; Huang C
PLoS One; 2012; 7(4):e35682. PubMed ID: 22532870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
